2.40 USD
↗ 0.09 (3.98%)LIVE (AS OF 03:21 PM EDT)
Cel-Sci Corporation
CVMAMEX • USD
Market: OPEN
Cel-Sci Corporation (CVM) trades at $2.40 per share. CVM shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, CVM trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.39
High?$2.70
Low?$2.34
Prev. Close?$2.31
Volume?615.1K
Avg. Volume?161.2K
VWAP?$2.51
Rel. Volume?3.81x
Bid / Ask
Bid?$2.41 × 4.0K
Ask?$2.44 × 100
Spread?$0.03
Midpoint?$2.43
Valuation & Ratios
Market Cap?40.6M
Shares Out?17.5M
Float?8.2M
Float %?96.0%
P/E Ratio?N/A
P/B Ratio?3.71
EPS?-$1.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Themes
Employees
44
Market Cap
40.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1983-12-08
Address
8229 BOONE BLVD .
VIENNA, VA 22182
Phone: (703) 506-9460
VIENNA, VA 22182
Phone: (703) 506-9460
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?70
Piotroski F-Score?0/9Weak
Altman Z-Score?-37.41Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?7.60%Elevated
Short Interest?619.3K
Days to Cover?5.6
Free Float8.2M
Avg Daily Volume110.3K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.48Adequate
Quick Ratio?1.42Adequate
Cash Ratio?1.29Strong
Debt/Equity?0.57Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.71FAIR▾
Peers100
S&P47
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-207.2%WEAK▾
S&P3
ROA?-106.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-16751398
Enterprise Value?$40.4M
Fundamentals ratios updated end of day